Rakuten TV Launches its AVOD Service in Europe
15.10.2019 11:30:00 EEST | Business Wire | Press release
Rakuten TV, one of the leading video-on-demand platforms in Europe, today announced the launch of its first AVOD - ad-supported video-on-demand - channels within the platform. This new business model will allow viewers to watch a wide range of content for free.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191015005048/en/
Rakuten TV's new UI 4.0 including "Free" section (Photo: Rakuten TV)
The free section of Rakuten TV will launch with an initial offer including Hollywood and local content to be expanded to additionally include exclusive Rakuten content, TV series, documentary series, news and sport channels in the coming months - with a combined linear and on-demand offer.
Among the exclusive content, Rakuten TV will present on its AVOD channel Matchday - Inside FC Barcelona, the new documentary series about FC Barcelona from the inside, offering previously unseen and exclusive scenes from the players’ private lives. Narrated by John Malkovich, Matchday – Inside FC Barcelona is a creation of Barça Studios, FC Barcelona’s own production house, in collaboration with Kosmos Studios, Rakuten, Inc. in association with Rakuten H Collective Studio and Producciones del Barrio.
Expanding its business model proposition, Rakuten TV will be the first to combine TVOD and AVOD products across Europe, meeting the changing needs of viewers. The free ad-supported channels will enrich the original proposition of Rakuten TV - Your Cinema at Home - offering Smart TV viewers the best cinematic experience with the latest new releases in the best audiovisual quality. Thanks to the presence of a remote control button providing direct access to the app on major Smart TVs, Rakuten TV content will be just a click away for over 30 million households across Europe.
In a time when the streaming industry is increasingly changing and exploring avenues such as AVOD, Rakuten TV is proud to pioneer this trend in Europe as the main VOD platform combining different business models - TVOD, AVOD and SVOD - which are oriented around meeting all audience needs.
Jacinto Roca, Rakuten TV Founder and CEO, stated: “We are incredibly proud to take this step after having tripled our presence in Europe just a few months ago. Rakuten TV continues to evolve rapidly alongside consumer trends within the industry, where there is a clear trend of advertisers moving away from linear TV and towards VOD. This is a unique opportunity for Rakuten TV which has already direct access to millions of European households through its branded remote control button of the main Smart TV brands. This is the mere beginning of a huge project which will see the launch of additional channels and exclusive content in the coming months”.
The service will be available in beta version, across the complete 2019 SMART TV line up, and will be progressively rolled out in other platforms including mobile and desktop.
Advertising sales will be managed by Rakuten Marketing, a subsidiary of Rakuten Inc. Nick Stamos, Rakuten Marketing CEO, stated: “Advertisers and agencies are eager to be among the first to showcase their brands in this exclusive and groundbreaking advertising platform. As VOD is emerging as a powerful media channel, our clients have been anticipating this launch from RakutenTV, so we are very excited to bring this new proposition to market across Europe.”
Rakuten Viber, Rakuten’s instant messaging service, will also be involved in the project, leveraging its community of 2 million Barça fans to promote Matchday.
Nielsen will be the data partner (DMP-data management platform) used to target advertisements at a digital level
This news comes alongside a renewed platform design for Rakuten TV, with a more attractive look & feel, a more intuitive user interface and a simpler user journey. Within the new interface, viewers will discover the new channel offering featuring ad-supported content inside the ‘free’ section implemented within the header menu.
The announcement took place during the conference “AVOD on the Rise” at MIPCOM 2019, where Founder and CEO of Rakuten TV, Jacinto Roca, spoke about the AVOD industry and its evolution with other top players in the entertainment field.
Rakuten TV
Rakuten TV is one of the leading Video On-Demand platforms in Europe. It offers a TVOD service (Transactional VOD) providing viewers a true cinematic experience with the latest new releases in the best audiovisual quality. It also includes an AVOD (Advertising VOD) section, Rakuten TV Free, in a blend of thematic channels embracing Hollywood classics, local, exclusive and themed content, all for free.
Rakuten TV is available in 42 countries and forms part of Rakuten, Inc., one of the world’s leading internet services companies, offering a wide variety of services for consumers and businesses, with a focus on e-commerce, fintech and digital content. Rakuten, headquartered in Japan, is also known for its partnerships with FC Barcelona, the NBA, the Golden State Warriors, Davis Cup and Spartan Race.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191015005048/en/
Contact information
Media Contacts:
For further information please contact:
Premier PR – Rakuten TV
Charlie Wainwright - Premier PR on behalf of Rakuten TV
charlie.wainwright@premiercomms.com
0207 292 7372
Rakuten TV
Fabiana Cumia – Communication Director – fabiana.cumia@rakuten.com
Iraia Arza – PR & Communication Specialist – iraia.arza@rakuten.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indication. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors, BeOne Medicines, said: “HERIZON‑GEA‑01 has the potential to shift the treatment paradigm in this historically difficult-to-treat disease, with the TEVIMBRA-containing arm demonstrating an unprecedented 26-month survival benefit. The FDA’s Prior
European Commission (EC) Approves Henlius and Organon’s POHERDY ® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 12:30:00 EEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
CORRECTING and REPLACING Yoshihiro Shimamura, a Leading Investor in Japan’s Entertainment Industry, to Host Workshop at the 2026 Cannes Film Festival29.4.2026 11:49:00 EEST | Press release
Headline of release dated April 27, 2026 should read: Yoshihiro Shimamura, a Leading Investor in Japan’s Entertainment Industry, to Host Workshop at the 2026 Cannes Film Festival The updated release reads: YOSHIHIRO SHIMAMURA, A LEADING INVESTOR IN JAPAN’S ENTERTAINMENT INDUSTRY, TO HOST WORKSHOP AT THE 2026 CANNES FILM FESTIVAL Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 11:27:00 EEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 11:00:00 EEST | Press release
Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, where human creativity is renewed through technology. Leading the jury will be Gabriele Salvatores, Italian director and screenwriter known for films such as Nirvana, Siberian Education, and Napoli - New York, and Academy Award® winner for Best Foreign Language Film with Mediterraneo. Joining him on the panel for the third edit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom